Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. (Q48326374)

10 February 2018

title

Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. (English)

1 reference

10 February 2018

0 references

0 references

Ohara K

1

1 reference

10 February 2018

Nagai M

2

1 reference

10 February 2018

Tani K

3

1 reference

10 February 2018

Nakamura Y

4

1 reference

10 February 2018

Ino A

5

1 reference

10 February 2018

Ohara K

6

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychiatry Research

1 reference

10 February 2018

volume

81

1 reference

10 February 2018

page(s)

117-123

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Dopamine D2 receptors in schizophrenia studied in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Positive and negative schizophrenia symptoms and the role of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

No D2 receptor increase in PET study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Haloperidol treatment increases D2 dopamine receptor protein independently of RNA levels in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Dopamine receptors and schizophrenia: drug effect or illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Increased brain dopamine and dopamine receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Central D2 receptors and negative symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Analysis of the 5'-flanking promoter region of the 5-HT2A receptor gene in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

The abundance of mRNA for dopamine D2 receptor isoforms in brain tissue from controls and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900092-4

7 January 2021

10.1016/S0165-1781(98)00092-4

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9858029

1 reference

10 February 2018